Interleukin-12 in Treating Patients With Advanced Cancer

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
National Cancer Institute (NCI)
ClinicalTrials.gov Identifier:
NCT00003330
First received: November 1, 1999
Last updated: February 8, 2013
Last verified: May 2001